REVENUE - Additional Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Number of reportable segments | segment	2
Revenue, net	$ 257,307	$ 253,739	$ 197,323
Contract receivables, current	1,800	1,500	1,200
Contract receivables, noncurrent	5,900	5,100	4,100
Current portion of deferred revenue, and other	8,300	9,600	9,900
Exchange rate impact	100
Contract liabilities, increase due to additional deferred sales	8,800	6,500
Revenue recognized, net of additional deferred sales	$ 10,900
Contract liabilities, revenue recognized		6,800
Contract cost average term	6 years
Capitalized contract costs	$ 5,000	4,100	3,000
Capitalized contract costs, amortization	1,500	1,100
Capitalized contract costs during the period	2,400	2,200
VetZ GmbH
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Contract liabilities, increase due to additional deferred sales	900
North America Segment | Operating Segments
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	161,762	158,898	131,066
International Segment | Operating Segments
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	95,545	94,841	66,257
POC Lab Instruments & Other | North America Segment | Operating Segments
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	17,178	14,837	13,663
POC Lab Instruments & Other | International Segment | Operating Segments
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	15,660	15,001	7,782
POC Lab Consumables | North America Segment | Operating Segments
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	78,302	72,004	59,247
POC Lab Consumables | International Segment | Operating Segments
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	41,205	46,016	32,354
POC Imaging & Informatics | North America Segment | Operating Segments
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	27,335	29,512	20,651
POC Imaging & Informatics | International Segment | Operating Segments
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	35,209	28,492	22,537
PVD | North America Segment | Operating Segments
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	22,020	24,939	19,810
PVD | International Segment | Operating Segments
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	3,471	5,332	3,584
OVP | North America Segment | Operating Segments
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	16,927	17,606	17,695
OVP | International Segment | Operating Segments
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	$ 95,545	$ 94,841	$ 66,257